Osimertinib-Related Hematological and Pulmonary Toxicities in Advanced NSCLC Patients: Combined Analysis of Phase III Trials-MedSci.cn

Osimertinib-Related Hematological and Pulmonary Toxicities in Advanced NSCLC Patients: Combined Analysis of Phase III Trials

Swarup, S; Thein, K; Ball, S; Quirch, M; Vorakunthada, Y; Sultan, A; Hardwicke, F; Tijani, L; Awasthi, S

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (10): S902

科室
- - 订阅+
  - 更多科室
工具
服务